Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GENFIT S.A.

< Previous 1 2 3 Next >
News headline image
GENFIT Advances Nangibotide in Phase 2 Clinical Investigation in ACLF
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT Highlights Long-Term Commercial Opportunity for its MASH Diagnostics Technology
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT to Host Virtual KOL Event Focused on MASH Diagnostics on September 9, 2026
From GENFIT S.A.
Via GlobeNewswire
News headline image
Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT Announces U.S. Medicare Coverage and Future Reimbursement for NASHnext®, a Non-Invasive Diagnostic Technology to Identify Patients with At-Risk MASH
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT: Positive Phase 1b Data with GNS561 in Combination Therapy in Heavily Pretreated Patients with Cholangiocarcinoma
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT: June 15, 2026 Combined Shareholders Meeting Results
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT: NASHnext®, Powered by GENFIT's Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp’s OnDemand Offering for Identification of At-Risk MASH
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT Highlights Broad Scientific and Strategic Presence at EASL Congress 2026
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT Reports First Quarter 2026 Financial Information and Provides a Corporate Update
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT Annual Combined General Meeting of June 15, 2026 — Availability of Preparatory Documents
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT: Publication of the 2026 Extra-Financial Report (fiscal year 2025)
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT Announces Publication of the 2025 Universal Registration Document
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT Reports Full-Year 2025 Financial Results and Provides Corporate Update
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT Receives FDA Orphan Drug Designation for NTZ for the treatment of ACLF
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT Reports Fourth Quarter 2025 Financial Information and Provides a Corporate Update
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT to receive US$20M milestone after Ipsen’s Iqirvo® exceeds the US$200M threshold in its first full year of net sales
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT Announces 2026 Financial Calendar
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT: Favorable Phase 1 Safety Profile and Strong Anti-Inflammatory Activity for ACLF Lead Asset G1090N
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT Announces Appointment of new Chief Medical Officer
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT Reports Third Quarter 2025 Financial Information and Provides a Corporate Update
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting® 2025
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT announces intention to voluntarily delist American Depositary Shares from The Nasdaq Global Select Market
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting® 2025
From GENFIT S.A.
Via GlobeNewswire
News headline image
GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update
From GENFIT S.A.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback